Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nanotechnological applications to open up new opportunities to treat diseases in 15 years time

19.09.2006
On Friday 15th, the Spanish Nanomedicine Platform (Nanomed Spain) and the European Technology Platform on Nanomedicine presented reports on the current status of nanomedicine in Spain and the strategic lines of action at European level to promote R+D in this field.

Both organizations coincide in emphasising that nanotechnology may have direct applications in medicine by contributing to improvements in health and quality of life, and moreover at a reduced cost. The Spanish report, in addition, estimates that the advances currently being developed in this field will reach the health system in the next fifteen years.

However, in its report entitled “Strategic vision of nanomedicine in Spain”, the Nanomed Spain Platform states that nanomedicine is currently in embryonary stage and that it is necessary to strengthen an industrial sector that allows scientific and technological advances to be transferred to specific applications in the health system.

Josep Samitier, coordinator of the Nanomed Spain Platform, affirmed that “Spain can play a relevant role in the development of this field because it has cutting-edge research centres, industrial and pharmaceutical sectors that are interested in using new technologies, as well as a health care system based on a network of hospitals that performs international basic and clinical research”.

According to the report by the Nanomed Spain Platform, as an innovative sector, nanomedicine requires larges investments, will be developed towards applications which yield a significant benefit and in addition, will respond to the health care issues which until now have not been addressed because of scientific or financial limitations.

In this regard, in its Strategic Research Agenda (SRA), the European Technology Platform on Nanomedicine has defined the priority lines of development in European R+D in nanomedicine for the coming years. These lines focus on cardiovascular diseases, cancer, muscular-skeletal disorders, neurodegenerative diseases, diabetes and bacterial and viral infectious diseases, such as AIDS. According to this report, these priorities have been established because they produce a considerable decrease in the quality of life, have a high social and economic cost and because nanotechnology can contribute to the healing process.

These two reports coincide in three application lines for nanomedicine: diagnosis, drug delivery and regenerative medicine. In the first field, devices or sensors will be developed that allow a faster and more reliable diagnosis in early stages of the disease and at a low cost in most cases, for example, cancer.

Regarding drug delivery, nanotechnological advances will allow the effective introduction of the so-called “personalized therapy”, such as administration of a small dose of a drug to obtain maximum effect; the reduction of secondary effects by means of drugs that act only on the therapeutic target; or the development of new more effective administration routes which are comfortable for the patient, such as the nasal administration of insulin. In this regard, for cancer patients, drug delivery systems will be directed exclusively to cancerous cells, thereby avoiding the secondary effects of present chemotherapy protocols.

Another field for the application of nanotechnology is regenerative medicine, in which it will allow the substitution of cells or tissues that do not work for equivalent ones that do, for example in the case of patients with degenerative diseases; as well as tissue regeneration. In the case of cardiovascular diseases, nanotechnology offers the opportunity to develop intelligent nanobiomaterials for the regeneration of tissues, for example in the case of myocardial infarction.

Susana Herráiz | alfa
Further information:
http://www.pcb.ub.es/homePCB/live/en/o190.asp?nid=1336

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>